All Stories

  1. Unveiling the complexity of rifampicin drug susceptibility testing in Mycobacterium tuberculosis: comparative analysis with next-generation sequencing

    Article • Journal of Medical Microbiology, September 2024, Society for General Microbiology

    Dr Sabira Tahseen

  2. The value of histological examination in the diagnosis of tuberculous lymphadenitis in the era of rapid molecular diagnosis

    Article • Scientific Reports, May 2022, Springer Science + Business Media

    Dr Sabira Tahseen

  3. In vivo Microevolution of Mycobacterium tuberculosis and transient emergence of atpE_Ala63Pro mutation during treatment in a pre-XDR TB patient

    Article • European Respiratory Journal, November 2021, European Respiratory Society (ERS)

    Dr Sabira Tahseen

  4. Population structure, biogeography and transmissibility of Mycobacterium tuberculosis

    Article • Nature Communications, October 2021, Springer Science + Business Media

    Dr Sabira Tahseen

  5. Mycobacterium tuberculosis borderline rpoB mutations: emerging from the unknown

    Article • European Respiratory Journal, April 2021, European Respiratory Society (ERS)

    Dr Sabira Tahseen

  6. Isolation of non-tuberculous mycobacteria among tuberculosis patients, a study from a tertiary care hospital in Lahore, Pakistan

    Article • BMC Infectious Diseases, April 2021, Springer Science + Business Media

    Dr Sabira Tahseen

  7. Acquisition of Cross-Resistance to Bedaquiline and Clofazimine following Treatment for Tuberculosis in Pakistan

    Article • International Journal of Mycobacteriology, January 2021, Medknow

    Dr Sabira Tahseen

  8. Second-line injectable drugs for rifampicin-resistant tuberculosis: better the devil we know?

    Article • Journal of Antimicrobial Chemotherapy, December 2020, Oxford University Press (OUP)

    Dr Sabira Tahseen

  9. Isoniazid resistance profile and associated levofloxacin and pyrazinamide resistance in rifampicin resistant and sensitive isolates/from pulmonary and extrapulmonary tuberculosis patients in Pakistan: A laboratory based surveillance study 2015-19

    Article • PLoS ONE, September 2020, PLOS

    Dr Sabira Tahseen

  10. Extrapulmonary tuberculosis in Pakistan- A nation-wide multicenter retrospective study

    Article • PLoS ONE, April 2020, PLOS

    Dr Sabira Tahseen

  11. World Health Organization 2018 treatment guidelines for rifampicin-resistant tuberculosis: uncertainty, potential risks and the way forward

    Article • International Journal of Antimicrobial Agents, January 2020, Elsevier

    Dr Sabira Tahseen

  12. Acquisition of Cross-Resistance to Bedaquiline and Clofazimine following Treatment for Tuberculosis in Pakistan

    Article • Antimicrobial Agents and Chemotherapy, September 2019, ASM Journals

    Dr Sabira Tahseen

  13. Is the public-private mix approach increasing tuberculosis case notification in Azad Jammu and Kashmir, Pakistan? A cross-sectional study

    Article • F1000Research, January 2019, Faculty of 1000, Ltd.

    Aashifa Yaqoob, Ahmad Wali, Razia Fatima, Dr Sabira Tahseen

  14. Population Based National Tuberculosis Prevalence Survey among Adults (>15 Years) in Pakistan, 2010–2011

    Article • PLoS ONE, February 2016, PLOS

    Dr Sabira Tahseen

  15. Judging respiratory specimen acceptability for AFB microscopy: visual vs. microscopic screening

    Article • Tropical Medicine & International Health, May 2009, Wiley

    Dr Sabira Tahseen